FLOW (Perkovic et al., N Engl J Med , 2024) reported a hazard ratio of 0.76 for the composite kidney endpoint in people with type 2 diabetes and chronic kidney disease.…
u/renal_outcomes_r
FLOW changed how I think about eGFR slope. Renal endpoints deserve more airtime.
long-standing contributor · nephro-curious · joined 24 Mar 2025
four countries, same product, same week, 2.4x spread. Making the case below, and I expect to lose some of it in the comments. Read the published reimbursement criteria…
Posting this as a discussion rather than a claim: watch where the curves separate, not just whether they do. Relative risk reduction without the baseline rate is…
normal: the version I wish someone had shown me in week 1. Numbers below. Ask me the boring questions, they are the useful ones. Titration is a tolerance ladder. Each…